Metabolic regulation by p53 family members

Cell Metabolism

Volumn 18, Issue 5, 2013, Pages 617-633

  Berkers, Celia R ^a   Maddocks, Oliver D K ^a   Cheung, Eric C ^a   Mor, Inbal ^a   Vousden, Karen H ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P53; PROTEIN P63; PROTEIN P73; REACTIVE OXYGEN METABOLITE; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR NRF2;

AGING; AUTOPHAGY; CARBOHYDRATE METABOLISM; CARBON METABOLISM; DIABETES MELLITUS; HOMEOSTASIS; HUMAN; LIPID METABOLISM; METABOLIC REGULATION; METABOLIC SYNDROME X; METABOLISM; NEOPLASM; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

AGING; ANIMALS; AUTOPHAGY; DISEASE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84887430076     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.06.019     Document Type: Review

References (181)

1. W.M. Abida, and W. Gu p53-Dependent and p53-independent activation of autophagy by ARF Cancer Res. 68 2008 352 357
2. N. Allocati, C. Di Ilio, and V. De Laurenzi p63/p73 in the control of cell cycle and cell death Exp. Cell Res. 318 2012 1285 1290
3. S. Ambs, M.O. Ogunfusika, W.G. Merriam, W.P. Bennett, T.R. Billiar, and C.C. Harris Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice Proc. Natl. Acad. Sci. USA 95 1998 8823 8828
4. K. Aquilano, S. Baldelli, B. Pagliei, S.M. Cannata, G. Rotilio, and M.R. Ciriolo p53 orchestrates the PGC-1α-mediated antioxidant response upon mild redox and metabolic imbalance Antioxid. Redox Signal. 18 2013 386 399
5. H.L. Armata, D. Golebiowski, D.Y. Jung, H.J. Ko, J.K. Kim, and H.K. Sluss Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis Mol. Cell. Biol. 30 2010 5787 5794
6. W. Assaily, D.A. Rubinger, K. Wheaton, Y. Lin, W. Ma, W. Xuan, L. Brown-Endres, K. Tsuchihara, T.W. Mak, and S. Benchimol ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress Mol. Cell 44 2011 491 501
7. M.V. Astle, K.M. Hannan, P.Y. Ng, R.S. Lee, A.J. George, A.K. Hsu, Y. Haupt, R.D. Hannan, and R.B. Pearson AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy Oncogene 31 2012 1949 1962
8. M. Bazuine, K.G. Stenkula, M. Cam, M. Arroyo, and S.W. Cushman Guardian of corpulence: a hypothesis on p53 signaling in the fat cell Clin Lipidol 4 2009 231 243
9. P. Beaconsfield, and H.W. Reading Pathways Of Glucose Metabolism And Nucleic Acid Synthesis Nature 202 1964 464 466
10. P. Beaconsfield, J. Ginsburg, and Z. Kosinski Glucose Metabolism Via The Pentose Phosphate Pathway Relative To Cell Replication And Immunological Response Nature 205 1965 50 51
11. K. Bensaad, A. Tsuruta, M.A. Selak, M.N. Vidal, K. Nakano, R. Bartrons, E. Gottlieb, and K.H. Vousden TIGAR, a p53-inducible regulator of glycolysis and apoptosis Cell 126 2006 107 120
12. K. Bensaad, E.C. Cheung, and K.H. Vousden Modulation of intracellular ROS levels by TIGAR controls autophagy EMBO J. 28 2009 3015 3026
13. D. Berchtold, and T.C. Walther TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain Mol. Biol. Cell 20 2009 1565 1575
14. P. Bertheau, M. Espié, E. Turpin, J. Lehmann, L.F. Plassa, M. Varna, A. Janin, and H. de Thé TP53 status and response to chemotherapy in breast cancer Pathobiology 75 2008 132 139
15. M.V. Blagosklonny Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression? Aging (Albany NY) 4 2012 450 455
16. R. Boidot, F. Végran, A. Meulle, A. Le Breton, C. Dessy, P. Sonveaux, S. Lizard-Nacol, and O. Feron Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors Cancer Res. 72 2012 939 948
17. L.G. Boros, J. Puigjaner, M. Cascante, W.N. Lee, J.L. Brandes, S. Bassilian, F.I. Yusuf, R.D. Williams, P. Muscarella, W.S. Melvin, and W.J. Schirmer Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation Cancer Res. 57 1997 4242 4248
18. L.G. Boros, P.W. Lee, J.L. Brandes, M. Cascante, P. Muscarella, W.J. Schirmer, W.S. Melvin, and E.C. Ellison Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? Med. Hypotheses 50 1998 55 59
19. A. Bourdon, L. Minai, V. Serre, J.P. Jais, E. Sarzi, S. Aubert, D. Chrétien, P. de Lonlay, V. Paquis-Flucklinger, and H. Arakawa Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion Nat. Genet. 39 2007 776 780
20. C.A. Brady, D. Jiang, S.S. Mello, T.M. Johnson, L.A. Jarvis, M.M. Kozak, D. Kenzelmann Broz, S. Basak, E.J. Park, and M.E. McLaughlin Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression Cell 145 2011 571 583
21. A.V. Budanov, and M. Karin p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling Cell 134 2008 451 460
22. M. Buzzai, R.G. Jones, R.K. Amaravadi, J.J. Lum, R.J. DeBerardinis, F. Zhao, B. Viollet, and C.B. Thompson Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth Cancer Res. 67 2007 6745 6752
23. C.E. Cano, J. Gommeaux, S. Pietri, M. Culcasi, S. Garcia, M. Seux, S. Barelier, S. Vasseur, R.P. Spoto, and M.J. Pébusque Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function Cancer Res. 69 2009 219 226
24. C. Cantó, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J.C. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 458 2009 1056 1060
25. W. Chen, Z. Sun, X.J. Wang, T. Jiang, Z. Huang, D. Fang, and D.D. Zhang Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response Mol. Cell 34 2009 663 673
26. W. Chen, T. Jiang, H. Wang, S. Tao, A. Lau, D. Fang, and D.D. Zhang Does Nrf2 contribute to p53-mediated control of cell survival and death? Antioxid. Redox Signal. 17 2012 1670 1675
27. E.C. Cheung, R.L. Ludwig, and K.H. Vousden Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death Proc. Natl. Acad. Sci. USA 109 2012 20491 20496
28. E.C. Cheung, D. Athineos, P. Lee, R.A. Ridgway, W. Lambie, C. Nixon, D. Strathdee, K. Blyth, O.J. Sansom, and K.H. Vousden TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis Dev. Cell 25 2013 463 477
29. A.R. Choudhury, Z. Ju, M.W. Djojosubroto, A. Schienke, A. Lechel, S. Schaetzlein, H. Jiang, A. Stepczynska, C. Wang, and J. Buer Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation Nat. Genet. 39 2007 99 105
30. T. Contractor, and C.R. Harris p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2 Cancer Res. 72 2012 560 567
31. D. Crighton, S. Wilkinson, J. O'Prey, N. Syed, P. Smith, P.R. Harrison, M. Gasco, O. Garrone, T. Crook, and K.M. Ryan DRAM, a p53-induced modulator of autophagy, is critical for apoptosis Cell 126 2006 121 134
32. D. Crighton, J. O'Prey, H.S. Bell, and K.M. Ryan p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death Cell Death Differ. 14 2007 1071 1079
33. Z. Derdak, C.H. Lang, K.A. Villegas, M. Tong, N.M. Mark, S.M. de la Monte, and J.R. Wands Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease J. Hepatol. 54 2011 164 172
34. Z. Derdak, K.A. Villegas, R. Harb, A.M. Wu, A. Sousa, and J.R. Wands Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease J. Hepatol. 58 2013 785 791
35. L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery Jr., J.S. Butel, and A. Bradley Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 356 1992 215 221
36. E. Drakos, V. Atsaves, J. Li, V. Leventaki, M. Andreeff, L.J. Medeiros, and G.Z. Rassidakis Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma Leukemia 23 2009 784 790
37. K.G. Eby, J.M. Rosenbluth, D.J. Mays, C.B. Marshall, C.E. Barton, S. Sinha, K.N. Johnson, L. Tang, and J.A. Pietenpol ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy Mol. Cancer 9 2010 95
38. A.A. Eid, B.M. Ford, K. Block, B.S. Kasinath, Y. Gorin, G. Ghosh-Choudhury, J.L. Barnes, and H.E. Abboud AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes J. Biol. Chem. 285 2010 37503 37512
39. M. Fanciulli, T. Bruno, S. Castiglione, C. Del Carlo, M.G. Paggi, and A. Floridi Glucose metabolism in adriamycin-sensitive and -resistant LoVo human colon carcinoma cells Oncol. Res. 5 1993 357 362
40. R. Faraonio, P. Vergara, D. Di Marzo, M.G. Pierantoni, M. Napolitano, T. Russo, and F. Cimino p53 suppresses the Nrf2-dependent transcription of antioxidant response genes J. Biol. Chem. 281 2006 39776 39784
41. Z. Feng, and A.J. Levine The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein Trends Cell Biol. 20 2010 427 434
42. Z. Feng, H. Zhang, A.J. Levine, and S. Jin The coordinate regulation of the p53 and mTOR pathways in cells Proc. Natl. Acad. Sci. USA 102 2005 8204 8209
43. Z. Feng, W. Hu, E. de Stanchina, A.K. Teresky, S. Jin, S. Lowe, and A.J. Levine The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways Cancer Res. 67 2007 3043 3053
44. A. Ferretti, L.L. Chen, M. Di Vito, S. Barca, M. Tombesi, M. Cianfriglia, A. Bozzi, R. Strom, and F. Podo Pentose phosphate pathway alterations in multi-drug resistant leukemic T-cells: 31P NMR and enzymatic studies Anticancer Res. 13 1993 867 872
45. E.R. Flores, and G. Lozano The p53 family grows old Genes Dev. 26 2012 1997 2000
46. D. Franck, L. Tracy, H.L. Armata, C.L. Delaney, D.Y. Jung, H.J. Ko, H. Ong, J.K. Kim, H. Scrable, and H.K. Sluss Glucose Tolerance in Mice is Linked to the Dose of the p53 Transactivation Domain Endocr Res. 38 2013 139 150
47. W.A. Freed-Pastor, H. Mizuno, X. Zhao, A. Langerød, S.H. Moon, R. Rodriguez-Barrueco, A. Barsotti, A. Chicas, W. Li, and A. Polotskaia Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway Cell 148 2012 244 258
48. C. Gaiddon, M. Lokshin, J. Ahn, T. Zhang, and C. Prives A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain Mol. Cell. Biol. 21 2001 1874 1887
49. I. García-Cao, M. García-Cao, J. Martín-Caballero, L.M. Criado, P. Klatt, J.M. Flores, J.C. Weill, M.A. Blasco, and M. Serrano "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally EMBO J. 21 2002 6225 6235
50. T. Gessner, L.A. Vaughan, B.C. Beehler, C.J. Bartels, and R.M. Baker Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells Cancer Res. 50 1990 3921 3927
51. I. Goldstein, and V. Rotter Regulation of lipid metabolism by p53 - fighting two villains with one sword Trends Endocrinol. Metab. 23 2012 567 575
52. D.R. Green, and G. Kroemer Cytoplasmic functions of the tumour suppressor p53 Nature 458 2009 1127 1130
53. A.V. Gudkov, K.V. Gurova, and E.A. Komarova Inflammation and p53: A Tale of Two Stresses Genes Cancer 2 2011 503 516
54. P. Hallenborg, S. Feddersen, L. Madsen, and K. Kristiansen The tumor suppressors pRB and p53 as regulators of adipocyte differentiation and function Expert Opin. Ther. Targets 13 2009 235 246
55. D.G. Hardie, F.A. Ross, and S.A. Hawley AMPK: a nutrient and energy sensor that maintains energy homeostasis Nat. Rev. Mol. Cell Biol. 13 2012 251 262
56. C. Hinault, D. Kawamori, C.W. Liew, B. Maier, J. Hu, S.R. Keller, R.G. Mirmira, H. Scrable, and R.N. Kulkarni Δ40 Isoform of p53 controls β-cell proliferation and glucose homeostasis in mice Diabetes 60 2011 1210 1222
57. G.W. Hinkal, C.E. Gatza, N. Parikh, and L.A. Donehower Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging Mech. Ageing Dev. 130 2009 262 271
58. M. Hollstein, D. Sidransky, B. Vogelstein, and C.C. Harris p53 mutations in human cancers Science 253 1991 49 53
59. H.F. Horn, and K.H. Vousden Coping with stress: multiple ways to activate p53 Oncogene 26 2007 1306 1316
60. J.J. Howell, and B.D. Manning mTOR couples cellular nutrient sensing to organismal metabolic homeostasis Trends Endocrinol. Metab. 22 2011 94 102
61. W. Hu, C. Zhang, R. Wu, Y. Sun, A. Levine, and Z. Feng Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function Proc. Natl. Acad. Sci. USA 107 2010 7455 7460
62. Y. Huang, L.N. Bell, J. Okamura, M.S. Kim, R.P. Mohney, R. Guerrero-Preston, and E.A. Ratovitski Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance Cell Cycle 11 2012 3810 3827
63. Y. Huang, R. Guerrero-Preston, and E.A. Ratovitski Phospho- ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation Cell Cycle 11 2012 1247 1259
64. T. Ide, L. Brown-Endres, K. Chu, P.P. Ongusaha, T. Ohtsuka, W.S. El-Deiry, S.A. Aaronson, and S.W. Lee GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress Mol. Cell 36 2009 379 392
65. K. Imamura, T. Ogura, A. Kishimoto, M. Kaminishi, and H. Esumi Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line Biochem. Biophys. Res. Commun. 287 2001 562 567
66. D. Italiano, A.M. Lena, G. Melino, and E. Candi Identification of NCF2/p67phox as a novel p53 target gene Cell Cycle 11 2012 4589 4596
67. E. Jacinto, R. Loewith, A. Schmidt, S. Lin, M.A. Rüegg, A. Hall, and M.N. Hall Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive Nat. Cell Biol. 6 2004 1122 1128
68. M. Jalving, J.A. Gietema, J.D. Lefrandt, S. de Jong, A.K. Reyners, R.O. Gans, and E.G. de Vries Metformin: taking away the candy for cancer? Eur. J. Cancer 46 2010 2369 2380
69. P. Jiang, W. Du, X. Wang, A. Mancuso, X. Gao, M. Wu, and X. Yang p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase Nat. Cell Biol. 13 2011 310 316
70. P. Jiang, W. Du, A. Mancuso, K.E. Wellen, and X. Yang Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence Nature 493 2013 689 693
71. R.G. Jones, D.R. Plas, S. Kubek, M. Buzzai, J. Mu, Y. Xu, M.J. Birnbaum, and C.B. Thompson AMP-activated protein kinase induces a p53-dependent metabolic checkpoint Mol. Cell 18 2005 283 293
72. M.Y. Kang, H.B. Kim, C. Piao, K.H. Lee, J.W. Hyun, I.Y. Chang, and H.J. You The critical role of catalase in prooxidant and antioxidant function of p53 Cell Death Differ. 20 2013 117 129
73. K. Kawauchi, K. Araki, K. Tobiume, and N. Tanaka Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation Biochem. Biophys. Res. Commun. 372 2008 137 141
74. K. Kawauchi, K. Araki, K. Tobiume, and N. Tanaka p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation Nat. Cell Biol. 10 2008 611 618
75. K. Kawauchi, K. Araki, K. Tobiume, and N. Tanaka Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification Proc. Natl. Acad. Sci. USA 106 2009 3431 3436
76. W.M. Keyes, Y. Wu, H. Vogel, X. Guo, S.W. Lowe, and A.A. Mills p63 deficiency activates a program of cellular senescence and leads to accelerated aging Genes Dev. 19 2005 1986 1999
77. R. Kiffin, C. Christian, E. Knecht, and A.M. Cuervo Activation of chaperone-mediated autophagy during oxidative stress Mol. Biol. Cell 15 2004 4829 4840
78. N. Kitamura, Y. Nakamura, Y. Miyamoto, T. Miyamoto, K. Kabu, M. Yoshida, M. Futamura, S. Ichinose, and H. Arakawa Mieap, a p53-inducible protein, controls mitochondrial quality by repairing or eliminating unhealthy mitochondria PLoS ONE 6 2011 e16060
79. J.A. Klein, C.M. Longo-Guess, M.P. Rossmann, K.L. Seburn, R.E. Hurd, W.N. Frankel, R.T. Bronson, and S.L. Ackerman The harlequin mouse mutation downregulates apoptosis-inducing factor Nature 419 2002 367 374
80. H. Kondoh, M.E. Lleonart, J. Gil, J. Wang, P. Degan, G. Peters, D. Martinez, A. Carnero, and D. Beach Glycolytic enzymes can modulate cellular life span Cancer Res. 65 2005 177 185
81. L.G. Korotchkina, O.V. Leontieva, E.I. Bukreeva, Z.N. Demidenko, A.V. Gudkov, and M.V. Blagosklonny The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway Aging (Albany NY) 2 2010 344 352
82. J.P. Kruse, and W. Gu Modes of p53 regulation Cell 137 2009 609 622
83. M. Kulawiec, V. Ayyasamy, and K.K. Singh p53 regulates mtDNA copy number and mitocheckpoint pathway J. Carcinog. 8 2009 8
84. S. Langbein, M. Zerilli, A. Zur Hausen, W. Staiger, K. Rensch-Boschert, N. Lukan, J. Popa, M.P. Ternullo, A. Steidler, and C. Weiss Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted Br. J. Cancer 94 2006 578 585
85. M. Laplante, and D.M. Sabatini mTOR signaling at a glance J. Cell Sci. 122 2009 3589 3594
86. M.A. Lebedeva, J.S. Eaton, and G.S. Shadel Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis Biochim. Biophys. Acta 1787 2009 328 334
87. G.M. Ledda-Columbano, A. Columbano, S. Dessì, P. Coni, C. Chiodino, and P. Pani Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules Carcinogenesis 6 1985 1371 1373
88. C.-H. Lee, K. Inoki, M. Karbowniczek, E. Petroulakis, N. Sonenberg, E.P. Henske, and K.L. Guan Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53 EMBO J. 26 2007 4812 4823
89. Y.G. Lee, S.W. Lee, H.S. Sin, E.J. Kim, and S.J. Um Kinase activity-independent suppression of p73alpha by AMP-activated kinase alpha (AMPKalpha) Oncogene 28 2009 1040 1052
90. C.-W. Lee, L.L.-Y. Wong, E.Y.-T. Tse, H.-F. Liu, V.Y.-L. Leong, J.M.-F. Lee, D.G. Hardie, I.O.-L. Ng, and Y.P. Ching AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells Cancer Res. 72 2012 4394 4404
91. I.H. Lee, Y. Kawai, M.M. Fergusson, I.I. Rovira, A.J.R. Bishop, N. Motoyama, L. Cao, and T. Finkel Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress Science 336 2012 225 228
92. O.V. Leontieva, V. Natarajan, Z.N. Demidenko, L.G. Burdelya, A.V. Gudkov, and M.V. Blagosklonny Hypoxia suppresses conversion from proliferative arrest to cellular senescence Proc. Natl. Acad. Sci. USA 109 2012 13314 13318
93. B. Levine, and G. Kroemer Autophagy in aging, disease and death: the true identity of a cell death impostor Cell Death Differ. 16 2009 1 2
94. H. Li, and G. Jogl Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator) J. Biol. Chem. 284 2009 1748 1754
95. T. Li, N. Kon, L. Jiang, M. Tan, T. Ludwig, Y. Zhao, R. Baer, and W. Gu Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence Cell 149 2012 1269 1283
96. C.C. Lin, T.L. Cheng, W.H. Tsai, H.J. Tsai, K.H. Hu, H.C. Chang, C.W. Yeh, Y.C. Chen, C.C. Liao, and W.T. Chang Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy Sci Rep 2 2012 785
97. S.P. Linke, K.C. Clarkin, A. Di Leonardo, A. Tsou, and G.M. Wahl A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage Genes Dev. 10 1996 934 947
98. G. Liu, and X. Chen The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis Oncogene 21 2002 7195 7204
99. K.M. Livesey, R. Kang, P. Vernon, W. Buchser, P. Loughran, S.C. Watkins, L. Zhang, J.J. Manfredi, H.J. Zeh III, and L. Li p53/HMGB1 complexes regulate autophagy and apoptosis Cancer Res. 72 2012 1996 2005
100. V.W. Lui, E.Y. Wong, K. Ho, P.K. Ng, C.P. Lau, S.K. Tsui, C.M. Tsang, S.W. Tsao, S.H. Cheng, and M.H. Ng Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death Oncogene 30 2011 1127 1134
101. J. Ma, Y. Meng, D.J. Kwiatkowski, X. Chen, H. Peng, Q. Sun, X. Zha, F. Wang, Y. Wang, and Y. Jing Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade J. Clin. Invest. 120 2010 103 114
102. O.D.K. Maddocks, and K.H. Vousden Metabolic regulation by p53 J. Mol. Med. 89 2011 237 245
103. O.D.K. Maddocks, C.R. Berkers, S.M. Mason, L. Zheng, K. Blyth, E. Gottlieb, and K.H. Vousden Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells Nature 493 2013 542 546
104. L.Y. Mah, J. O'Prey, A.D. Baudot, A. Hoekstra, and K.M. Ryan DRAM-1 encodes multiple isoforms that regulate autophagy Autophagy 8 2012 18 28
105. B. Maier, W. Gluba, B. Bernier, T. Turner, K. Mohammad, T. Guise, A. Sutherland, M. Thorner, and H. Scrable Modulation of mammalian life span by the short isoform of p53 Genes Dev. 18 2004 306 319
106. M.C. Maiuri, L. Galluzzi, E. Morselli, O. Kepp, S.A. Malik, and G. Kroemer Autophagy regulation by p53 Curr. Opin. Cell Biol. 22 2010 181 185
107. A. Matheu, A. Maraver, P. Klatt, I. Flores, I. Garcia-Cao, C. Borras, J.M. Flores, J. Viña, M.A. Blasco, and M. Serrano Delayed ageing through damage protection by the Arf/p53 pathway Nature 448 2007 375 379
108. S.P. Mathupala, C. Heese, and P.L. Pedersen Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53 J. Biol. Chem. 272 1997 22776 22780
109. S. Matoba, J.G. Kang, W.D. Patino, A. Wragg, M. Boehm, O. Gavrilova, P.J. Hurley, F. Bunz, and P.M. Hwang p53 regulates mitochondrial respiration Science 312 2006 1650 1653
110. E.M. Matthew, L.S. Hart, A. Astrinidis, A. Navaraj, N.G. Dolloff, D.T. Dicker, E.P. Henske, and W.S. El-Deiry The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions Cell Cycle 8 2009 4168 4175
111. S.K. McBrayer, M. Yarrington, J. Qian, G. Feng, M. Shanmugam, V. Gandhi, N.L. Krett, and S.T. Rosen Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms PLoS ONE 7 2012 e41455
112. S.M. Mendrysa, K.A. O'Leary, M.K. McElwee, J. Michalowski, R.N. Eisenman, D.A. Powell, and M.E. Perry Tumor suppression and normal aging in mice with constitutively high p53 activity Genes Dev. 20 2006 16 21
113. A.P. Miceli, A.J. Saporita, and J.D. Weber Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint Mol. Cell. Biol. 32 2012 348 364
114. E.M. Michalak, A. Villunger, J.M. Adams, and A. Strasser In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute Cell Death Differ. 15 2008 1019 1029
115. T. Minamino, M. Orimo, I. Shimizu, T. Kunieda, M. Yokoyama, T. Ito, A. Nojima, A. Nabetani, Y. Oike, and H. Matsubara A crucial role for adipose tissue p53 in the regulation of insulin resistance Nat. Med. 15 2009 1082 1087
116. Y. Mitsuishi, K. Taguchi, Y. Kawatani, T. Shibata, T. Nukiwa, H. Aburatani, M. Yamamoto, and H. Motohashi Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming Cancer Cell 22 2012 66 79
117. A. Molchadsky, I. Shats, N. Goldfinger, M. Pevsner-Fischer, M. Olson, A. Rinon, E. Tzahor, G. Lozano, D. Zipori, R. Sarig, and V. Rotter p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner PLoS ONE 3 2008 e3707
118. S. Mordier, C. Deval, D. Béchet, A. Tassa, and M. Ferrara Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway J. Biol. Chem. 275 2000 29900 29906
119. E. Morselli, E. Tasdemir, M.C. Maiuri, L. Galluzzi, O. Kepp, A. Criollo, J.M. Vicencio, T. Soussi, and G. Kroemer Mutant p53 protein localized in the cytoplasm inhibits autophagy Cell Cycle 7 2008 3056 3061
120. E. Morselli, L. Galluzzi, O. Kepp, J.-M. Vicencio, A. Criollo, M.C. Maiuri, and G. Kroemer Anti- and pro-tumor functions of autophagy Biochim. Biophys. Acta 1793 2009 1524 1532
121. P.A. Muller, P.T. Caswell, B. Doyle, M.P. Iwanicki, E.H. Tan, S. Karim, N. Lukashchuk, D.A. Gillespie, R.L. Ludwig, and P. Gosselin Mutant p53 drives invasion by promoting integrin recycling Cell 139 2009 1327 1341
122. S.K. Mungamuri, X. Yang, A.D. Thor, and K. Somasundaram Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53 Cancer Res. 66 2006 4715 4724
123. L.E. Nelson, R.J. Valentine, J.M. Cacicedo, M.-S. Gauthier, Y. Ido, and N.B. Ruderman A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells Am. J. Physiol. Cell Physiol. 303 2012 C4 C13
124. S. Okamura, C.C. Ng, K. Koyama, Y. Takei, H. Arakawa, M. Monden, and Y. Nakamura Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system Oncol. Res. 11 1999 281 285
125. M.A. Peña-Rico, M.N. Calvo-Vidal, R. Villalonga-Planells, F. Martínez-Soler, P. Giménez-Bonafé, A. Navarro- Sabaté, A. Tortosa, R. Bartrons, and A. Manzano TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells Radiother. Oncol. 101 2011 132 139
126. T.R. Peterson, S.S. Sengupta, T.E. Harris, A.E. Carmack, S.A. Kang, E. Balderas, D.A. Guertin, K.L. Madden, A.E. Carpenter, B.N. Finck, and D.M. Sabatini mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway Cell 146 2011 408 420
127. A. Ramos-Montoya, W.N. Lee, S. Bassilian, S. Lim, R.V. Trebukhina, M.V. Kazhyna, C.J. Ciudad, V. Noé, J.J. Centelles, and M. Cascante Pentose phosphate cycle oxidative and nonoxidative balance: A new vulnerable target for overcoming drug resistance in cancer Int. J. Cancer 119 2006 2733 2741
128. S. Reef, and A. Kimchi Nucleolar p19ARF, unlike mitochondrial smARF, is incapable of inducing p53-independent autophagy Autophagy 4 2008 866 869
129. A. Rivera, and S.A. Maxwell The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway J. Biol. Chem. 280 2005 29346 29354
130. S. Ros, C.R. Santos, S. Moco, F. Baenke, G. Kelly, M. Howell, N. Zamboni, and A. Schulze Functional metabolic screen identifies 6-phosphofructo-2-kinase/ fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival Cancer Discov 2 2012 328 343
131. J.M. Rosenbluth, and J.A. Pietenpol mTOR regulates autophagy-associated genes downstream of p73 Autophagy 5 2009 114 116
132. J.M. Rosenbluth, D.J. Mays, M.F. Pino, L.J. Tang, and J.A. Pietenpol A gene signature-based approach identifies mTOR as a regulator of p73 Mol. Cell. Biol. 28 2008 5951 5964
133. J.M. Rosenbluth, D.J. Mays, A. Jiang, Y. Shyr, and J.A. Pietenpol Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis Proc. Natl. Acad. Sci. USA 108 2011 2076 2081
134. B. Rotblat, G. Melino, and R.A. Knight NRF2 and p53: Januses in cancer? Oncotarget 3 2012 1272 1283
135. D.C. Rubinsztein, P. Codogno, and B. Levine Autophagy modulation as a potential therapeutic target for diverse diseases Nat. Rev. Drug Discov. 11 2012 709 730
136. A. Rufini, M.V. Niklison-Chirou, S. Inoue, R. Tomasini, I.S. Harris, A. Marino, M. Federici, D. Dinsdale, R.A. Knight, G. Melino, and T.W. Mak TAp73 depletion accelerates aging through metabolic dysregulation Genes Dev. 26 2012 2009 2014
137. P. Ruiz-Lozano, M.L. Hixon, M.W. Wagner, A.I. Flores, S. Ikawa, A.S. Baldwin Jr., K.R. Chien, and A. Gualberto p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression Cell Growth Differ. 10 1999 295 306
138. V. Sabbisetti, A. Di Napoli, A. Seeley, A.M. Amato, E. O'Regan, M. Ghebremichael, M. Loda, and S. Signoretti p63 promotes cell survival through fatty acid synthase PLoS ONE 4 2009 e5877
139. E. Sahin, and R.A. DePinho Axis of ageing: telomeres, p53 and mitochondria Nat. Rev. Mol. Cell Biol. 13 2012 397 404
140. E. Sahin, S. Colla, M. Liesa, J. Moslehi, F.L. Müller, M. Guo, M. Cooper, D. Kotton, A.J. Fabian, and C. Walkey Telomere dysfunction induces metabolic and mitochondrial compromise Nature 470 2011 359 365
141. N. Sanchez-Macedo, J. Feng, B. Faubert, N. Chang, A. Elia, E.J. Rushing, K. Tsuchihara, D. Bungard, S.L. Berger, and R.G. Jones Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model Cell Death Differ. 20 2013 659 668
142. C.R. Santos, and A. Schulze Lipid metabolism in cancer FEBS J. 279 2012 2610 2623
143. R. Scherz-Shouval, H. Weidberg, C. Gonen, S. Wilder, Z. Elazar, and M. Oren p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation Proc. Natl. Acad. Sci. USA 107 2010 18511 18516
144. F. Schwartzenberg-Bar-Yoseph, M. Armoni, and E. Karnieli The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression Cancer Res. 64 2004 2627 2633
145. N. Sen, Y.K. Satija, and S. Das PGC-1α, a key modulator of p53, promotes cell survival upon metabolic stress Mol. Cell 44 2011 621 634
146. S. Sengupta, T.R. Peterson, and D.M. Sabatini Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress Mol. Cell 40 2010 310 322
147. D.B. Shackelford, E. Abt, L. Gerken, D.S. Vasquez, A. Seki, M. Leblanc, L. Wei, M.C. Fishbein, J. Czernin, P.S. Mischel, and R.J. Shaw LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin Cancer Cell 23 2013 143 158
148. L. Smeenk, and M. Lohrum Behind the scenes: unravelling the molecular mechanisms of p53 target gene selectivity (Review) Int. J. Oncol. 37 2010 1061 1070
149. M.B. Sporn, and K.T. Liby NRF2 and cancer: the good, the bad and the importance of context Nat. Rev. Cancer 12 2012 564 571
150. P. Stambolsky, L. Weisz, I. Shats, Y. Klein, N. Goldfinger, M. Oren, and V. Rotter Regulation of AIF expression by p53 Cell Death Differ. 13 2006 2140 2149
151. X. Su, M. Paris, Y.J. Gi, K.Y. Tsai, M.S. Cho, Y.L. Lin, J.A. Biernaskie, S. Sinha, C. Prives, and L.H. Pevny TAp63 prevents premature aging by promoting adult stem cell maintenance Cell Stem Cell 5 2009 64 75
152. X. Su, Y.J. Gi, D. Chakravarti, I.L. Chan, A. Zhang, X. Xia, K.Y. Tsai, and E.R. Flores TAp63 is a master transcriptional regulator of lipid and glucose metabolism Cell Metab. 16 2012 511 525
153. K. Subbaramaiah, P. Michaluart, W.J. Chung, T. Tanabe, N. Telang, and A.J. Dannenberg Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells Ann. N Y Acad. Sci. 889 1999 214 223
154. S. Suzuki, T. Tanaka, M.V. Poyurovsky, H. Nagano, T. Mayama, S. Ohkubo, M. Lokshin, H. Hosokawa, T. Nakayama, and Y. Suzuki Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species Proc. Natl. Acad. Sci. USA 107 2010 7461 7466
155. J.V. Swinnen, K. Brusselmans, and G. Verhoeven Increased lipogenesis in cancer cells: new players, novel targets Curr. Opin. Clin. Nutr. Metab. Care 9 2006 358 365
156. I. Tanida, M. Yamasaki, M. Komatsu, and T. Ueno The FAP motif within human ATG7, an autophagy-related E1-like enzyme, is essential for the E2-substrate reaction of LC3 lipidation Autophagy 8 2012 88 97
157. E. Tasdemir, M.C. Maiuri, L. Galluzzi, I. Vitale, M. Djavaheri-Mergny, M. D'Amelio, A. Criollo, E. Morselli, C. Zhu, and F. Harper Regulation of autophagy by cytoplasmic p53 Nat. Cell Biol. 10 2008 676 687
158. X. Tong, F. Zhao, and C.B. Thompson The molecular determinants of de novo nucleotide biosynthesis in cancer cells Curr. Opin. Genet. Dev. 19 2009 32 37
159. S.D. Tyner, S. Venkatachalam, J. Choi, S. Jones, N. Ghebranious, H. Igelmann, X. Lu, G. Soron, B. Cooper, and C. Brayton p53 mutant mice that display early ageing-associated phenotypes Nature 415 2002 45 53
160. N. Vahsen, C. Candé, J.J. Brière, P. Bénit, N. Joza, N. Larochette, P.G. Mastroberardino, M.O. Pequignot, N. Casares, and V. Lazar AIF deficiency compromises oxidative phosphorylation EMBO J. 23 2004 4679 4689
161. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
162. J.M. Varley Germline TP53 mutations and Li-Fraumeni syndrome Hum. Mutat. 21 2003 313 320
163. A.V. Vaseva, N.D. Marchenko, K. Ji, S.E. Tsirka, S. Holzmann, and U.M. Moll p53 opens the mitochondrial permeability transition pore to trigger necrosis Cell 149 2012 1536 1548
164. K.H. Vousden, and C. Prives Blinded by the Light: The Growing Complexity of p53 Cell 137 2009 413 431
165. M.M. Wamelink, E.A. Struys, and C. Jakobs The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review J. Inherit. Metab. Dis. 31 2008 703 717
166. X. Wang, X. Zhao, X. Gao, Y. Mei, and M. Wu A new role of p53 in regulating lipid metabolism J Mol Cell Biol 5 2013 147 150
167. C. Wanka, J.P. Steinbach, and J. Rieger Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis J. Biol. Chem. 287 2012 33436 33446
168. P.S. Ward, and C.B. Thompson Metabolic reprogramming: a cancer hallmark even warburg did not anticipate Cancer Cell 21 2012 297 308
169. K.Y. Won, S.J. Lim, G.Y. Kim, Y.W. Kim, S.A. Han, J.Y. Song, and D.K. Lee Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer Hum. Pathol. 43 2012 221 228
170. N. Yahagi, H. Shimano, T. Matsuzaka, Y. Najima, M. Sekiya, Y. Nakagawa, T. Ide, S. Tomita, H. Okazaki, and Y. Tamura p53 Activation in adipocytes of obese mice J. Biol. Chem. 278 2003 25395 25400
171. N. Yahagi, H. Shimano, T. Matsuzaka, M. Sekiya, Y. Najima, S. Okazaki, H. Okazaki, Y. Tamura, Y. Iizuka, and N. Inoue p53 involvement in the pathogenesis of fatty liver disease J. Biol. Chem. 279 2004 20571 20575
172. Y.A. Yang, W.F. Han, P.J. Morin, F.J. Chrest, and E.S. Pizer Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase Exp. Cell Res. 279 2002 80 90
173. K.S. Yee, S. Wilkinson, J. James, K.M. Ryan, and K.H. Vousden PUMA- and Bax-induced autophagy contributes to apoptosis Cell Death Differ. 16 2009 1135 1145
174. K.A. Yoon, Y. Nakamura, and H. Arakawa Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses J. Hum. Genet. 49 2004 134 140
175. J. Yu, and L. Zhang PUMA, a potent killer with or without p53 Oncogene 27 Suppl 1 2008 S71 S83
176. K. Zaugg, Y. Yao, P.T. Reilly, K. Kannan, R. Kiarash, J. Mason, P. Huang, S.K. Sawyer, B. Fuerth, and B. Faubert Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress Genes Dev. 25 2011 1041 1051
177. J. Zawacka-Pankau, A. Kostecka, A. Sznarkowska, E. Hedström, and A. Kawiak p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach? Cell Cycle 9 2010 720 728
178. Y. Zhao, L. Chaiswing, J.M. Velez, I. Batinic-Haberle, N.H. Colburn, T.D. Oberley, and D.K. St Clair p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase Cancer Res. 65 2005 3745 3750
179. Y.G. Zhao, H. Zhao, L. Miao, L. Wang, F. Sun, and H. Zhang The p53-induced gene Ei24 is an essential component of the basal autophagy pathway J. Biol. Chem. 287 2012 42053 42063
180. J. Zhuang, W. Ma, C.U. Lago, and P.M. Hwang Metabolic regulation of oxygen and redox homeostasis by p53: lessons from evolutionary biology? Free Radic. Biol. Med. 53 2012 1279 1285
181. R. Zoncu, A. Efeyan, and D.M. Sabatini mTOR: from growth signal integration to cancer, diabetes and ageing Nat. Rev. Mol. Cell Biol. 12 2011 21 35